Corcept Therapeutics Incorporated (CORT)

Corcept Therapeutics Revenue

Corcept Therapeutics had revenue of $157.21M in the quarter ending March 31, 2025, with 7.09% growth. This brings the company's revenue in the last twelve months to $685.45M, up 30.93% year-over-year. In the year 2024, Corcept Therapeutics had annual revenue of $675.04M with 39.94% growth.

• Revenue (ttm): $685.45M
• Revenue Growth: +30.93%
• P/S Ratio: 10.88
• Revenue / Employee: $1,370,892
• Employees: 500
• Market Cap: 7.58B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	675.04M	192.67M	39.94%
Dec 31, 2023	482.38M	80.52M	20.04%
Dec 31, 2022	401.86M	35.88M	9.80%
Dec 31, 2021	365.98M	12.10M	3.42%
Dec 31, 2020	353.87M	47.39M	15.46%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.